HSTC (HST Global) Quick Ratio: 0.09 (As of Dec. 2024)


HSTC HST Global Inc HSTC
40 GF Score
Price $0.70
View Full Analysis

What is HST Global Quick Ratio?

HST Global HSTC 40 Quick Ratio is 0.09 as of Dec. 2024. GuruFocus rates HSTC with a GF Score™ of 40/100.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. HST Global's quick ratio for the quarter that ended in Dec. 2024 was 0.09.

HST Global has a quick ratio of 0.09. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for HST Global's Quick Ratio or its related term are showing as below:

HSTC's Quick Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful Quick Ratio only.

HST Global  (OTCPK:HSTC) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


HST Global Quick Ratio Related Terms


HST Global Quick Ratio Historical Data

* Premium members only.

The historical data trend for HST Global's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HST Global Quick Ratio Chart

HST Global Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.00 0.00 0.00 0.09

HST Global Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.22 0.24 0.09

HSTC vs PYXS, PYPD, IMUX: Quick Ratio Comparison

For the Biotechnology subindustry, HST Global's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HST Global Quick Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HST Global's Quick Ratio distribution charts can be found below:

* The bar in red indicates where HST Global's Quick Ratio falls into.


HSTC
40GF Score
HST Global Inc HSTC
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HST Global Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

HST Global's Quick Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Quick Ratio (A: Dec. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.029-0)/0.341
=0.09

HST Global's Quick Ratio for the quarter that ended in Dec. 2024 is calculated as

Quick Ratio (Q: Dec. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.029-0)/0.341
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.09 mean?
HST Global (HSTC) has a Quick Ratio of 0.09 as of Dec. 2024. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on HST Global and its competitors.
Is HST Global's Quick Ratio too high?
HST Global's current Quick Ratio is 0.09. The Biotechnology industry median Quick Ratio is 3.60. HST Global's value of 0.09 is 97.5% below this industry median. Overall, HST Global has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does HST Global's Quick Ratio compare to PYXS and PYPD?
HST Global's Quick Ratio of 0.09 can be compared against companies in the Biotechnology industry. The industry median Quick Ratio is 3.60. HST Global's value of 0.09 is 97.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,417 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HST Global's current Quick Ratio of 0.09 is 97.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on HST Global and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HST Global's current Quick Ratio is 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HST Global stock overvalued right now?
HST Global (HSTC) has a current Quick Ratio of 0.09. The current Quick Ratio is 0.09 and 97.5% below the Biotechnology industry median of 3.60. HST Global's overall GF Score™ is 40/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For HST Global (HSTC), the current Quick Ratio is 0.09 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HST Global Business Description

Address 509 Old Great Neck Road, Suite 105, Virginia Beach, VA, USA, 23454
HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers focused on homeopathic and alternative treatments for late-stage cancer. Further, it focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out throughout the United States.
40GF Score

Get the complete analysis for HSTC

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.70
Price